Skip to main content

Fed

8
Pipeline Programs
1
Companies
8
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
8
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Dr. Reddy's Laboratories
8 programs
8
Amlodipine Besylate/Benazepril HClPhase 11 trial
CIPRO®XRPhase 11 trial
DesloratadinePhase 11 trial
Mycophenolate MofetilPhase 11 trial
OlanzapinePhase 11 trial
+3 more programs
Active Trials
NCT01505998Completed49Est. May 2007
NCT01372358Completed32Est. Feb 2005
NCT01314352Completed28Est. Mar 2006
+5 more trials

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Dr. Reddy's LaboratoriesOlanzapine
Dr. Reddy's LaboratoriesMycophenolate Mofetil
Dr. Reddy's LaboratoriesAmlodipine Besylate/Benazepril HCl
Dr. Reddy's LaboratoriesOlanzapine OD Tablets 5 mg
Dr. Reddy's LaboratoriesDesloratadine
Dr. Reddy's LaboratoriesCIPRO®XR
Dr. Reddy's LaboratoriesPantoprazole Sodium
Dr. Reddy's LaboratoriesReminyl

Clinical Trials (8)

Total enrollment: 351 patients across 8 trials

NCT01503424Dr. Reddy's LaboratoriesOlanzapine

Bioequivalence Study of Olanzapine Tablets, 5 mg Under Fed Study

Start: Aug 2011Est. completion: Sep 201148 patients
Phase 1Completed
NCT01283867Dr. Reddy's LaboratoriesMycophenolate Mofetil

Bioequivalence Study of Mycophenolate Mofetil 500 mg Tablets of Dr.Reddy's Laboratories Limited Under Non-Fasting Conditions

Start: Nov 2007Est. completion: Dec 200792 patients
Phase 1Completed
NCT01505998Dr. Reddy's LaboratoriesAmlodipine Besylate/Benazepril HCl

Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules of Dr. Reddy's Under Fed Conditions

Start: Mar 2007Est. completion: May 200749 patients
Phase 1Completed
NCT01503450Dr. Reddy's LaboratoriesOlanzapine OD Tablets 5 mg

Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fed Condition

Start: Nov 2006Est. completion: Dec 200626 patients
Phase 1Completed
NCT01314352Dr. Reddy's LaboratoriesDesloratadine

Bioavailability Study of Desloratadine 5 mg Tablet of Dr. Reddy's Under Fed Conditions

Start: Dec 2005Est. completion: Mar 200628 patients
Phase 1Completed
NCT01372358Dr. Reddy's LaboratoriesCIPRO®XR

Bioavailability Study of Ciprofloxacin 1000 mg ER Tablets of Dr. Reddy's Under Non-Fasting Conditions

Start: Jan 2005Est. completion: Feb 200532 patients
Phase 1Completed
NCT01283932Dr. Reddy's LaboratoriesPantoprazole Sodium

Bioequivalence Study of Pantoprazole Sodium DR Tablets 40 mg of Dr. Reddy's Laboratories Limited Under Fed Condition

Start: Oct 2004Est. completion: Dec 200452 patients
Phase 1Completed
NCT01372306Dr. Reddy's LaboratoriesReminyl

Galantamine Bioequivalence Study of Dr. Reddy's Under Fed Condition

Start: Oct 2004Est. completion: Nov 200424 patients
Phase 1Completed

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.